0001782959-22-000001.txt : 20220613 0001782959-22-000001.hdr.sgml : 20220613 20220613102235 ACCESSION NUMBER: 0001782959-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 EFFECTIVENESS DATE: 20220613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Capital Rx, Inc. CENTRAL INDEX KEY: 0001782959 IRS NUMBER: 352612946 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-448935 FILM NUMBER: 221010915 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: SUITE 87234 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 855-538-8897 MAIL ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: SUITE 87234 CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0001782959 Capital Rx, Inc. 228 PARK AVENUE S. SUITE 87234 NEW YORK NY NEW YORK 10003 855-538-8897 DELAWARE Capital RX, LLC None Corporation true 2017 A. J. Loiacono 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Director Ryan Kelly 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Director Joseph Alexander 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Lenard Marcus 281 Witherspoon Street Princeton NJ NEW JERSEY 08540 Director Laleh Alemzadeh 228 Park Avenue S. Suite 87234 New York NY NEW YORK 10003 Executive Officer Secretary Kevin Hill 4 Somerset Dr. Rumson NJ NEW JERSEY 07760 Director Jared Kesselheim c/o Transformation Capital, Attn: CFO 1 Federal Street, 25th Floor Boston MA MASSACHUSETTS 02110 Director Robert Mittendorff 1240 Rosecrans Ave. Manhattan Beach CA CALIFORNIA 90266 Director Appointed 5/27/2022 Other Decline to Disclose 06b false 2022-05-27 false true false 0 105999993 105999993 0 false 9 0 0 0 false Capital Rx, Inc. /s/ A.J. Loiacono A.J. Loiacono CEO 2022-06-13